Raphael Pharmaceutical (RAPH) Accounts Payables (2020 - 2025)
Raphael Pharmaceutical (RAPH) posted Accounts Payables of $163000.0 for Q4 2025, up 30.4% sequentially from $125000.0 in Q4 2024, and up 30.4% YoY from $125000.0 in Q4 2024.
Raphael Pharmaceutical (RAPH) Accounts Payables (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical has reported Accounts Payables for 6 years, with the latest figure at $163000.0 in Q4 2025.
- Quarterly Accounts Payables rose 30.4% year-over-year to $163000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $163000.0 (up 30.4% YoY) and the FY2025 annual result came in at $163000.0, up 30.4% from the prior year.
- Accounts Payables grew to $163000.0 in Q4 2025 per RAPH's latest filing, from $125000.0 in the prior quarter.
- Over five years, Accounts Payables peaked at $272000.0 in Q4 2021 and troughed at $12000.0 in Q3 2021.
- A 5-year average of $118833.3 and a median of $98500.0 in 2022 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2021 and 2022: Accounts Payables surged 2922.22% in 2021, then tumbled 73.53% in 2022.
- Over 5 years, Accounts Payables stood at $272000.0 in 2021, then sank by 73.53% to $72000.0 in 2022, then fell by 4.17% to $69000.0 in 2023, then soared by 81.16% to $125000.0 in 2024, then surged by 30.4% to $163000.0 in 2025.
- According to Business Quant data, Accounts Payables over the past three periods registered $163000.0, $125000.0, and $69000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 356.00 Mn |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 163,000.00 |
| Dec 31, 2024 | 125,000.00 |
| Dec 31, 2023 | 69,000.00 |
| Dec 31, 2022 | 72,000.00 |
| Dec 31, 2021 | 272,000.00 |
| Sep 30, 2021 | 12,000.00 |
| Dec 31, 2020 | 9,000.00 |